September 24, 2020 | Meredith Cohn
Institute of Human Virology
Chief Communications & Public Affairs Officer
(443) 823-0613 (phone)
(410) 706-1952 (fax)
Tuesday, January 31, 2023
University of Maryland School of Medicine’s Institute of Human Virology Director Dr. Robert Gallo Co-Authors STAT Op-Ed with a U.S. Government Call to Action and Road Map for the Future of COVID-19
STAT today published "How the Biden administration’s Covid preparedness policies could narrow America’s political divide" co-authored by leadership of the Global Virus Network (GVN), representing 68 Centers of Excellence and 11 Affiliates in 37 countries, and comprising foremost experts in every class of virus causing disease in humans and some animals. The opinion piece calls on the Biden Administration to “follow the science” in updating COVID-19 preparedness policies to align with the indefinite endemic phase the country is now facing.
Wednesday, January 18, 2023
Acquired immune deficiency syndrome, AIDS, had been recognized as a new disease in 1981, when an increasing number of young homosexuals died of unusual infections and rare cancers. It was also known to affect intravenous drug users and some were known to have contracted it through blood transfusions.
Wednesday, January 18, 2023
When monkeypox cases began spiking in early June, some of those infected and at risk were dismayed that there weren’t proven therapies ready. There was a promising treatment, tested in animals but not humans, for the infections regularly seen in Africa but rarely reported in Europe or North America. The drug was used sparingly before the emergency began abating. But instead of putting the tecovirimat, or TPOXX, back on the shelf, researchers at Johns Hopkins and elsewhere launched a major study to confirm it worked for monekypox, now known as mpox.
Friday, January 06, 2023
The claim: There is no proof HIV is the cause of AIDS. A Dec. 15 Facebook video shows Kary Mullis, a scientist known for denying the link between HIV and AIDS, claiming again there is no proof HIV is the cause of AIDS. The post was shared more than 1,000 times in a week. The clip comes from a 2009 documentary that promoted AIDS denialism, which has more than 300,000 views on YouTube.
Tuesday, August 09, 2022
CNBC: ‘We don’t even agree on how to define it yet’: It’s year three of the pandemic and scientists still know very little about long COVID
We’ve entered year three of the pandemic, and experts still know very little about long Covid, including how to cure its symptoms. On July 20th and July 21st, the Global Virus Network hosted the first-ever conference devoted solely to the science of long COVID. There, scientists spoke openly about what is known about the mysterious condition and the questions that remain.
Monday, July 25, 2022
Institute of Human Virology at the University of Maryland School of Medicine Supports First-of-Its-Kind Conference to Evaluate the Public Health Magnitude of Long COVID And Define A Global Research Roadmap to Address the Crisis
The conference, hosted at the University of Maryland, Baltimore, reviewed the wealth of cohort data on long COVID, constructed a framework to characterize and define the conditions, and identified the most critical and urgent areas of research needed to better understand, diagnose, and treat this developing public health crisis.
Friday, July 22, 2022
Presented by the Global Virus Network, a coalition of leading virologists, the two-day virtual conference convened at the University of Maryland, Baltimore where experts across disciplines and around the world to ask and answer questions about what causes long COVID, how to predict who gets it, how to treat it, and just possibly how to prevent it.
Tuesday, May 24, 2022
Officials from the U.S. Centers for Disease Control and Prevention warned the public and medical providers Monday to be on alert for possible cases of monkeypox as it counts up to five cases of the normally rare disease around the nation. But the officials say the threat to the general public remains low, as it’s just not as easily spread as other diseases such as COVID-19. Rather, it takes touching or sharing fluids with someone with the characteristic monkeypox rash.
Thursday, May 19, 2022
Dan Rodricks: I recently had conversations with a middle-aged man who is extremely careful about what he puts into his body. He eats lots of fruits and vegetables and stays away from red meat and processed foods. He also refuses to get the vaccine against COVID-19, even as infections are on the rise again.
Tuesday, April 05, 2022
UM School Of Medicine Institute of Human Virology’s Robert Gallo Receives Distinguished Alumni Award by the University of Chicago Medical Association
Robert Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, Co-Founder and Director of the Institute Human Virology at the University of Maryland School of Medicine and Co-Founder and Chair of the Scientific Leadership Board of the Global Virus Network, was awarded the Distinguished Alumni Award by the University of Chicago Medical & Biological Sciences Alumni Association (UChicago MBSAA) for his lifetime achievements. Honorees will participate in a panel discussion on May 10 and will be presented the award on May 21 at the Hyde Parke campus.
Friday, March 18, 2022
Few scientists in the world can come up with as many successes as Robert Gallo: The US researcher was involved in the discovery of the AIDS virus, found leukemia pathogens and other deadly viruses. Now he is 85 - and works even harder than before.
Wednesday, February 23, 2022
Over two years since the first cases started appearing in Wuhan, China, there is much we don’t know about the origins of SARS-CoV-2, the virus causing COVID-19. But a quick resolution to that question is possible: scientists could find bats in a cave somewhere in China or in southeast Asia and trace a chain leading from those bats to the COVID-19 outbreak in Wuhan. Realistically, however, recent history offers little promise for this to happen quickly.
Wednesday, February 16, 2022
Scientists used a cutting-edge stem cell transplant method to treat a woman's HIV, but a lead researcher in Maryland said it's too soon to celebrate. A U.S. woman is the third known person who is in HIV remission after receiving stem cells from umbilical cord blood, an American research team announced Wednesday.
Tuesday, February 08, 2022
Could a “broad spectrum” booster increase our immunity to many pathogens simultaneously? The first tuberculosis vaccine was developed in 1921, by two French scientists, Albert Calmette and Camille Guérin. It was called Bacillus Calmette-Guérin, or B.C.G., and has long been one of the world’s most widely administered shots. From the beginning, its power was surprising. B.C.G. contains a bacterium similar to the one that causes TB, and engenders an immune defense specific to that disease. But, as Calmette noted in a paper in 1931, those vaccinated with B.C.G. at birth were around seventy-five per cent less likely to die in their early years of any cause.
Tuesday, January 04, 2022
Economy.bg asked scientists from Bulgaria and the world what they hope for in 2022.
Wednesday, December 22, 2021
Economy.bg asked scientists in our country and around the world what they think is the most important of the past 2021
Thursday, December 16, 2021
Robert Gallo, director and co-founder of the Institute of Human Virology at the University of Maryland and co-founder of the Global Virus Network, discussed why it is important to vaccinate children against coronavirus.
Tuesday, October 26, 2021
Correio Braziliense: "It's obvious that no vaccine causes AIDS," says one of the virologists who discovered HIV
The virologist, and one of the discoverers of HIV, speaks to Correio about statements by President Bolsonaro live on social media
Friday, July 23, 2021
People online claim the Olympics are in jeopardy because the country has no plan to vaccinate its population. That's false.
Thursday, July 08, 2021
Dr. Robert Gallo, The Global Virus Network Co-founder and Director at University of Maryland says COVID-19 is a solvable problem, as obviously it was easy to get a solvable vaccine.
Saturday, July 03, 2021
India Today: Exclusive: Virologist Dr. Robert Gallo Speaks On Third Wave, Effects On Children & Other COVID Issues
Will India and the world see a third wave, if yes then when? How much the third wave will affect children? If mRNA vaccine is the future of COVID-19 vaccines? World's top virologist, Dr. Robert Gallo, answers these and many other questions related to COVID-19 and its vaccination in an exclusive conversation with Rajdeep Sardesai.
Friday, June 25, 2021
Dr. Marc Siegel talks to the Co-founder & Director of the Institute of Human Virology at the University of Maryland School of Medicine and Co-founder for the Global Virus Network, Dr. Robert Gallo, as well as the President of the Global Virus Network, Dr. Christian Brechot, about COVID-19 Origin, Immunity, Vaccines, and Variants.
Friday, June 25, 2021
Weather Channel: Mystery Thickens Over COVID-19's Origin; Claims of Hidden Early Genetic Information Attracts Further Scrutiny
COVID-19 pandemic has been wreaking worldwide havoc for nearly 20 months now. Yet, Its origin and early spread continue to be one of the most intriguing scientific puzzles of recent history. Claims that the earliest coronavirus strains leaked out from a lab in the Wuhan Institute of Virology in China have resurfaced and subsided multiple times, throughout the course of the pandemic. While many such claims were eventually disregarded as unfounded speculations of conspiracy theorists, allegations have continued against the Wuhan lab having known about the infection and its subsequent threat, much before the world at large was aware.
Tuesday, June 22, 2021
The Wuhan lab has drawn global scrutiny because of its research on bat coronaviruses in the city where the pandemic began. The events have shined a light on a research niche that — in China, the United States and elsewhere — operates with heightened secrecy because of the national security risks of handling deadly pathogens.
Monday, June 21, 2021
A third wave of coronavirus infections is likely to hit India by October, and although it will be better controlled than the latest outbreak the pandemic will remain a public health threat for at least another year, according to a Reuters poll of medical experts.
Thursday, June 17, 2021
What has COVID-19 taught us about preparing for future epidemics? Can we trigger innate immune responses – our first lines of defense - to mitigate novel infections? Can we use live-attenuated vaccines (LAV) meant for other infections to protect us while we develop specific vaccines for new pathogens? On this episode, we talk to virologists Konstantin Chumakov and Robert Gallo about their recent paper entitled “Old vaccines for new infections”.
Thursday, June 03, 2021
More than a year into the COVID-19 pandemic, scientists still aren’t sure where exactly the virus that caused this mess came from, and how it was able to spread so rapidly among humans. With the origins of the coronavirus still up in the air, there’s been a lot of talk of the so-called lab leak theory—the idea that the virus spread to people in a laboratory accident, rather than jumping from a wild animal to a human. In recent days, there’s been a flurry of speculation, and it can be hard to parse what the lab leak theory is all about, how likely it is, and why it matters at all. Here’s our attempt to sort some of that out.
Tuesday, June 01, 2021
Inoculation with live attenuated vaccines (LAV) such as those used against TB, polio or measles can stimulate the immune system to provide protection against other infectious diseases, including COVID-19, says a new study. People who have been inoculated with one or more LAVs but have no access to the new, specific vaccines against COVID-19 — typically because they are expensive or in short supply — may have some protection during the current pandemic, according to the study.
Thursday, May 27, 2021
Baltimore Sun: Maryland researchers study whether HIV cure can come from infusing patients with genetically modified ‘super T cells’
A week ago, a Washington, D.C., man in his 30s with HIV became the first person to be infused with a heaping load of his own genetically modified cells that a Maryland biotech firm believes one day could lead to the elusive cure for the disease. American Gene Technologies’ method involves taking T cells out of a person’s blood and genetically modifying them in the lab to resist infection before they are reinfused. C. David Pauza is the company’s chief science officer and a former professor and researcher at the University of Maryland School of Medicine’s Institute for Human Virology. Another center evaluating entering the study is Maryland’s Institute for Human Virology, confirmed its co-founder and director, Dr. Robert Gallo, who is internationally regarded for his role in discovering HIV and developing a blood test to detect it.
Tuesday, May 18, 2021
Institute of Human Virology Leadership Contributes to Global Virus Network Analysis Suggesting Measles, Polio and Tuberculosis Vaccines May Boost Immunity to Coronavirus
Institute of Human Virology at the University of Maryland School of Maryland scientists, who are also members of the Global Virus Network (GVN), a coalition comprised of human and animal virologists from 63 Centers of Excellence and 11 Affiliates in 35 countries, and colleagues today published a perspective proposing that live attenuated vaccines (LAVs), such as those for tuberculosis, measles, and polio, may induce protective innate immunity that mitigate other infectious diseases, triggering the human body’s natural emergency response to infections including COVID-19 as well as future pandemic threats.
Monday, April 19, 2021
Dr. Robert Gallo, co-founder of the Global Virus Network and director of the Institute of Human Virology at the University of Maryland School of Medicine, discusses the global rollout of Covid-19 vaccines. Global cases passed 141 million, and deaths exceeded 3 million. Gallo speaks with Haidi Stroud-Watts and Shery Ahn on "Bloomberg Daybreak: Australia."
Monday, April 19, 2021
In an exclusive interview with CBN, Dr. Robert Gallo, a world-renowned virus expert, speculated that certain components of Johnson & Johnson and AstraZeneca vaccines may induce the immune system to produce an antibody, which can cause a very small number of people. Heparin-induced thrombocytopenia, thrombosis.
Friday, April 09, 2021
As the United States ramps up its COVID-19 inoculation campaign, aiming to make vaccines available to all adults by April 19, some doctors and health workers are concerned that brand preferences among potential vaccine recipients could hurt attempts to slow the spread of the virus.
Thursday, April 01, 2021
Can I still spread the coronavirus after I’m vaccinated? It’s possible. Experts say the risk is low, but are still studying how well the shots blunt the spread of the virus. The current vaccines are highly effective at preventing people from getting seriously sick with COVID-19.
Monday, December 21, 2020
Robert Gallo of the UM School of Medicine Institute of Human Virology and Global Virus Network Awarded Top Life Sciences and Medicine Prize from China
Robert C. Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine and co-founder and international scientific advisor of the Global Virus Network, was awarded the “VCANBIO Award for Biosciences and Medicine,” a significant and authoritative award in the life sciences and medicine field of China. The elite Prize is jointly presented by the University of Chinese Academy of Sciences and the VCANBIO CELL & GENE ENGINEERING CORP, LTD to push forward scientific research, technological innovation and continuous development in the life sciences and medicine field of China.
Friday, December 18, 2020
Robert Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine and co-founder and international scientific advisor of the Global Virus Network, was awarded Italy’s “Magna Graecia International Prize,” an award created in 1997 by the Magna Graecia Foundation that is bestowed to the most influential Italians and Italians of origin who have embodied and symbolized, in the most diverse sectors, the best qualities of Italy by extending Italian culture beyond national borders.
Thursday, October 08, 2020
In case you were still procrastinating getting a flu shot this year, here's another reason to make it a priority. There's a chance the vaccine could offer some protection against COVID-19 itself, says virologist Robert Gallo, who directs the Institute of Human Virology at the University of Maryland School of Medicine and is chairman of the Global Virus Network.
Friday, August 21, 2020
Institute of Human Virology and Italian Researchers identify a SARS-CoV-2 Viral Strain with Deletion in a Protein, Possibly Reducing Fatalities
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine, a Global Virus Network (GVN) Center of Excellence, in collaboration with scientists from Campus Biomedico in Rome, Italy announced today the results of studies showing the emergence of a SARS-CoV-2 viral strain with a deletion in a protein known as nsp1. These data, accepted for publication today by the Journal of Translational Medicine, (link here) may indicate the emergence of a less pathogenic viral strain.
Tuesday, June 30, 2020
Wall Street Journal Op-Ed: An Old Vaccine May Help Against Coronavirus: A tablet for polio boosts innate immunity, which fights other viruses.
In this op-ed coauthored by Dr. Robert C. Gallo and Daniel J. Arbess, they discuss how “An Old Vaccine May Help Against Coronavirus: A tablet for polio boosts innate immunity, which fights other viruses.”
Monday, June 29, 2020
Dr. Robert Gallo is featured in Baltimore Magazine's special edition, "On the Front Lines: Acts of Courage and Kindness in the Age of Coronavirus."
Friday, June 26, 2020
Links to news stories featuring the IHV from June 11 to June 25, 2020.
Thursday, June 11, 2020
The Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 53 Centers of Excellence, including the Institute of Human Virology at the University of Maryland School of Medicine, and 10 Affiliates in 32 countries, published a viewpoint in Science today that the stimulation of innate immunity by live attenuated vaccines in general, and oral poliovirus vaccine (OPV) in particular, could provide temporary protection against coronavirus disease 2019 (COVID-19).
Friday, May 01, 2020
What if We Already Have a Coronavirus Vaccine? Researchers are testing whether decades-old vaccines for polio and tuberculosis could protect against infection.
Wednesday, April 29, 2020
Please check out Dr. Robert Gallo’s C-SPAN Washington Journal appearance today to discuss COVID-19 treatments, vaccines, the need for the Global Virus Network, and more.
Monday, April 27, 2020
IHV Co-Founder and Director, Robert Gallo, MD is interviewed on LBC, a radio station in the United Kingdom. Darren Adam had Professor Gallo on the line to discuss his research in the past and the work he's carrying out during the coronavirus crisis. "We have learned to live with HIV" Darren began, listing out how it has changed from a death sentence to a disease that humans can live a long life with. He wondered if this could be possibly the path we're taking with Covid-19.
Wednesday, April 22, 2020
IndiaToday on Twitter - “Can oral polio vaccine help in fighting #Covid19? @DrRobertCGallo responds. #NewsToday with @sardesairajdeep
Friday, April 17, 2020
Dr. Robert Gallo discusses repurposing the oral polio vaccine, drug therapies and more on COVID-19 on CNN’s The Lead with Jake Tapper, April 17, 2020.
Monday, April 13, 2020
Please see this just released Associated Press article, “Could old vaccines for other germs protect against COVID-19?” with Dr. Robert Gallo (Institute of Human Virology at the University of Maryland School of Medicine) and Dr. Konstantin Chumakov (U.S. Food and Drug Administration), both of the Global Virus Network (GVN).
Wednesday, April 08, 2020
Institute of Human Virology Co-founder on Coronavirus Recovery, Antibody Testing, Drug Testing, Bloomberg TV
Dr. Robert Gallo, the Institute of Human Virology at the University of Maryland School of Medicine, Co-founder and director discusses the coronavirus. He speaks with Haidi Stroud-Watts and Shery Ahn on "Bloomberg Daybreak: Asia." (Source: Bloomberg)
Tuesday, April 07, 2020
(WNPR) Dr. Robert Gallo has been getting to know viruses-- their targets and their weaknesses--for decades, even before he co-discovered the virus that causes AIDS in the 1980s. At the University of Maryland’s Institute for Human Virology, which he heads, Gallo is looking at the coronavirus; he joins us to share his thoughts. Gallo is also co-founder and international scientific advisor at the Global Virus Network.
Wednesday, April 01, 2020
Robert Gallo, MD, Co-Founder and Director of the Institute of Human Virology, discusses SARS-CoV-2/COVID-19, specifically, how he thinks the fight against the Coronavirus is going thus far.
Friday, October 04, 2019
Institute of Human Virology Hosts 21st Annual International Meeting of Top Scientists on Ending the HIV/AIDS Epidemic in America and the Intersection of Opioid Use Disorder
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine commenced IHV2019 held Thursday, October 3 through Friday, October 4 at the Four Seasons Hotel in Baltimore, Maryland. This year “Progress in HIV/AIDS: Challenges in 2020” opened with highlights about the recent plan for "Ending the HIV Epidemic by 2030” with expert opinions by ADM Brett Giroir, MD, Assistant Secretary for Health at the U.S. Department of Health and Human Services (HHS)
Monday, August 26, 2019
Dr. Robert Gallo Featured in Malcolm Gladwell's Podcast, "Revisionist History: The Obscure Virus Club"
"Revisionist History" by Malcolm Gladwell: “The Obscure Virus Club,” featuring three prominent virologists, including Dr. Robert Gallo (as well as Dr. Ludwig Gross and Dr. Howard Temin).